Morning Watchlist: Apollo Investment, XOMA, Taminco, Hyperion Pharma
Shares in Apollo Investment Corporation (NASDAQ:AINV) dropped more than 5% pre-market after the company said it has priced a public offering of 12.0 million shares. Underwriters have the option to buy an additional 1.8 million shares. The company didn’t give the price of the offer. XOMA Corp (NASDAQ:XOMA) is moving nearly 5% higher after the drug maker announced that gevokizumab, the company’s IL-1 beta modulating … Continue reading Morning Watchlist: Apollo Investment, XOMA, Taminco, Hyperion Pharma